The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Metabolic complications with the use of mTOR inhibitors for cancer therapy: A systematic review and meta-analysis.
Shanthi Sivendran
No relevant relationships to disclose
Jian Ying
No relevant relationships to disclose
Benjamin Adam Gartrell
No relevant relationships to disclose
Neeraj Agarwal
No relevant relationships to disclose
Kenneth M. Boucher
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose
Guru Sonpavde
No relevant relationships to disclose
William K. Oh
No relevant relationships to disclose
Matt D. Galsky
No relevant relationships to disclose